Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 16, 2018
[ Fri, Mar 16th 2018
] - WOPRAI
[ Fri, Mar 16th 2018
] - WOPRAI
[ Fri, Mar 16th 2018
] - WOPRAI
[ Fri, Mar 16th 2018
] - WOPRAI
[ Fri, Mar 16th 2018
] - WOPRAI
[ Fri, Mar 16th 2018
] - WOPRAI
[ Fri, Mar 16th 2018
] - WOPRAI
Thu, March 15, 2018
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
Lawrence Keusch Initiated (ZBH) at Buy and Held Target at $135 on, Mar 15th, 2018
Lawrence Keusch of Raymond James, Initiated "Zimmer Biomet Holdings, Inc." (ZBH) at Buy and Held Target at $135 on, Mar 15th, 2018.
Lawrence has made no other calls on ZBH in the last 4 months.
There are 5 other peers that have a rating on ZBH. Out of the 5 peers that are also analyzing ZBH, 2 agree with Lawrence's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Amit Hazan of "Citigroup" Maintained at Hold with Decreased Target to $121 on, Wednesday, February 28th, 2018
- Isaac Ro of "Goldman Sachs" Upgraded from Strong Sell to Hold on, Wednesday, December 20th, 2017
These are the ratings of the 3 analyists that currently disagree with Lawrence
- David Lewis of "Morgan Stanley" Maintained at Buy with Decreased Target to $148 on, Monday, February 26th, 2018
- Richard Newitter of "Leerink Swann" Maintained at Buy with Increased Target to $146 on, Wednesday, January 31st, 2018
- Rick Wise of "Stifel" Upgraded from Hold to Strong Buy on, Wednesday, January 31st, 2018
